Global Next-Generation Bispecific Antibody Market Size, Share, and COVID-19 Impact Analysis, Russia-Ukraine War Impact, Tariff Analysis, By Type (Bispecific T-cell Engagers, Dual-Affinity Re-targeting Proteins, Nanobodies, and Others), By Indication Type (Cancer, Autoimmune Diseases, Infectious Diseases, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare
RELEASE DATE Sep 2025
REPORT ID SI15660
PAGES 229
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis, By Type
      2. Market Attractiveness Analysis, By Indication Type
      3. Market Attractiveness Analysis, By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Rising Disease Incidence
    3. Restraints
      1.  Lack of Infrastructure and Reimbursement
    4. Opportunities
      1.  Expanding Therapeutic Applications
    5. Challenges
      1. Complex Manufacturing & Impurities
  6. Global Next-Generation Bispecific Antibody Market Analysis and Projection, By Type
    1. Segment Overview
    2. Bispecific T-cell Engagers
    3. Dual-Affinity Re-targeting Proteins
    4. Nanobodies
    5. Others
  7. Global Next-Generation Bispecific Antibody Market Analysis and Projection, By Indication Type
    1. Segment Overview
    2. Cancer
    3. Autoimmune Diseases
    4. Infectious Diseases
    5. Others
  8. Global Next-Generation Bispecific Antibody Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  9. Global Next-Generation Bispecific Antibody Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Next-Generation Bispecific Antibody Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  10. Company Profiles
    1. Novartis
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Amgen 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Sanofi 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Roche 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Pfizer 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Celgene Corporation
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   AstraZeneca
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Johnson & Johnson
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Regeneron Pharmaceuticals
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  GSK plc 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Others
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Next-Generation Bispecific Antibody Market, By Type, 2024-2035(USD Billion)
  2. Global Bispecific T-cell Engagers, Next-Generation Bispecific Antibody Market, By Region, 2024-2035(USD Billion)
  3. Global Dual-Affinity Re-targeting Proteins, Next-Generation Bispecific Antibody Market, By Region, 2024-2035(USD Billion)
  4. Global Nanobodies, Next-Generation Bispecific Antibody Market, By Region, 2024-2035(USD Billion)
  5. Global Others, Next-Generation Bispecific Antibody Market, By Region, 2024-2035(USD Billion)
  6. Global Next-Generation Bispecific Antibody Market, By Indication Type, 2024-2035(USD Billion)
  7. Global Cancer, Next-Generation Bispecific Antibody Market, By Region, 2024-2035(USD Billion)
  8. Global Autoimmune Diseases, Next-Generation Bispecific Antibody Market, By Region, 2024-2035(USD Billion)
  9. Global Infectious Diseases, Next-Generation Bispecific Antibody Market, By Region, 2024-2035(USD Billion)
  10. Global Others, Next-Generation Bispecific Antibody Market, By Region, 2024-2035(USD Billion)
  11. North America Next-Generation Bispecific Antibody Market, By Type, 2024-2035(USD Billion)
  12. North America Next-Generation Bispecific Antibody Market, By Indication Type, 2024-2035(USD Billion)
  13. U.S.  Next-Generation Bispecific Antibody Market, By Type, 2024-2035(USD Billion)
  14. U.S.  Next-Generation Bispecific Antibody Market, By Indication Type, 2024-2035(USD Billion)
  15. Canada Next-Generation Bispecific Antibody Market, By Type, 2024-2035(USD Billion)
  16. Canada Next-Generation Bispecific Antibody Market, By Indication Type, 2024-2035(USD Billion)
  17. Mexico Next-Generation Bispecific Antibody Market, By Type, 2024-2035(USD Billion)
  18. Mexico Next-Generation Bispecific Antibody Market, By Indication Type, 2024-2035(USD Billion)
  19. Europe Next-Generation Bispecific Antibody Market, By Type, 2024-2035(USD Billion)
  20. Europe Next-Generation Bispecific Antibody Market, By Indication Type, 2024-2035(USD Billion)
  21. Germany Next-Generation Bispecific Antibody Market, By Type, 2024-2035(USD Billion)
  22. Germany Next-Generation Bispecific Antibody Market, By Indication Type, 2024-2035(USD Billion)
  23. France Next-Generation Bispecific Antibody Market, By Type, 2024-2035(USD Billion)
  24. France Next-Generation Bispecific Antibody Market, By Indication Type, 2024-2035(USD Billion)
  25. U.K.  Next-Generation Bispecific Antibody Market, By Type, 2024-2035(USD Billion)
  26. U.K.  Next-Generation Bispecific Antibody Market, By Indication Type, 2024-2035(USD Billion)
  27. Italy Next-Generation Bispecific Antibody Market, By Type, 2024-2035(USD Billion)
  28. Italy Next-Generation Bispecific Antibody Market, By Indication Type, 2024-2035(USD Billion)
  29. Spain Next-Generation Bispecific Antibody Market, By Type, 2024-2035(USD Billion)
  30. Spain Next-Generation Bispecific Antibody Market, By Indication Type, 2024-2035(USD Billion)
  31. Asia Pacific Next-Generation Bispecific Antibody Market, By Type, 2024-2035(USD Billion)
  32. Asia Pacific Next-Generation Bispecific Antibody Market, By Indication Type, 2024-2035(USD Billion)
  33. Japan Next-Generation Bispecific Antibody Market, By Type, 2024-2035(USD Billion)
  34. Japan Next-Generation Bispecific Antibody Market, By Indication Type, 2024-2035(USD Billion)
  35. China Next-Generation Bispecific Antibody Market, By Type, 2024-2035(USD Billion)
  36. China Next-Generation Bispecific Antibody Market, By Indication Type, 2024-2035(USD Billion)
  37. India Next-Generation Bispecific Antibody Market, By Type, 2024-2035(USD Billion)
  38. India Next-Generation Bispecific Antibody Market, By Indication Type, 2024-2035(USD Billion)
  39. South America Next-Generation Bispecific Antibody Market, By Type, 2024-2035(USD Billion)
  40. South America Next-Generation Bispecific Antibody Market, By Indication Type, 2024-2035(USD Billion)
  41. Brazil Next-Generation Bispecific Antibody Market, By Type, 2024-2035(USD Billion)
  42. Brazil Next-Generation Bispecific Antibody Market, By Indication Type, 2024-2035(USD Billion)
  43. The Middle East and Africa Next-Generation Bispecific Antibody Market, By Type, 2024-2035(USD   Billion)
  44. The Middle East and Africa Next-Generation Bispecific Antibody Market, By Indication Type, 2024-2035(USD   Billion)
  45. UAE Next-Generation Bispecific Antibody Market, By Type, 2024-2035(USD Billion)
  46. UAE Next-Generation Bispecific Antibody Market, By Indication Type, 2024-2035(USD Billion)
  47. South Africa Next-Generation Bispecific Antibody Market, By Type, 2024-2035(USD Billion)
  48. South Africa Next-Generation Bispecific Antibody Market, By Indication Type, 2024-2035(USD Billion)

 

List of Figures 

  1. Global Next-Generation Bispecific Antibody Market Segmentation
  2. Next-Generation Bispecific Antibody Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Next-Generation Bispecific Antibody Market
  9. Top Winning Strategies, 2024-2035
  10. Top Winning Strategies, By Development, 2024-2035(%)
  11. Top Winning Strategies, By Company, 2024-2035
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Next-Generation Bispecific Antibody Market
  20. Next-Generation Bispecific Antibody Market Segmentation, By Type
  21. Next-Generation Bispecific Antibody Market For Bispecific T-cell Engagers, By Region, 2024-2035 ($ Billion)
  22.  Next-Generation Bispecific Antibody Market For Dual-Affinity Re-targeting Proteins, By Region, 2024-2035 ($ Billion)
  23. Next-Generation Bispecific Antibody Market For Nanobodies, By Region, 2024-2035 ($ Billion)
  24. Next-Generation Bispecific Antibody Market For Others, By Region, 2024-2035 ($ Billion)
  25.  Next-Generation Bispecific Antibody Market Segmentation, By Indication Type
  26.  Next-Generation Bispecific Antibody Market For Cancer, By Region, 2024-2035 ($ Billion)
  27.  Next-Generation Bispecific Antibody Market For Autoimmune Diseases, By Region, 2024-2035 ($ Billion)
  28. Next-Generation Bispecific Antibody Market For Infectious Diseases, By Region, 2024-2035 ($ Billion)
  29. Next-Generation Bispecific Antibody Market For Others, By Region, 2024-2035 ($ Billion)
  30. Novartis: Net Sales, 2024-2035 ($ Billion)
  31. Novartis: Revenue Share, By Segment, 2024 (%)
  32. Novartis: Revenue Share, By Region, 2024 (%)
  33. Amgen: Net Sales, 2024-2035 ($ Billion)
  34. Amgen: Revenue Share, By Segment, 2024 (%)
  35. Amgen: Revenue Share, By Region, 2024 (%)
  36. Sanofi: Net Sales, 2024-2035 ($ Billion)
  37. Sanofi: Revenue Share, By Segment, 2024 (%)
  38. Sanofi: Revenue Share, By Region, 2024 (%)
  39. Roche: Net Sales, 2024-2035 ($ Billion)
  40. Roche: Revenue Share, By Segment, 2024 (%)
  41. Roche: Revenue Share, By Region, 2024 (%)
  42. Pfizer: Net Sales, 2024-2035 ($ Billion)
  43. Pfizer: Revenue Share, By Segment, 2024 (%)
  44. Pfizer: Revenue Share, By Region, 2024 (%)
  45. Celgene Corporation: Net Sales, 2024-2035 ($ Billion)
  46. Celgene Corporation: Revenue Share, By Segment, 2024 (%)
  47. Celgene Corporation: Revenue Share, By Region, 2024 (%)
  48. AstraZeneca: Net Sales, 2024-2035 ($ Billion)
  49. AstraZeneca: Revenue Share, By Segment, 2024 (%)
  50. AstraZeneca: Revenue Share, By Region, 2024 (%)
  51. Johnson & Johnson: Net Sales, 2024-2035 ($ Billion)
  52. Johnson & Johnson: Revenue Share, By Segment, 2024 (%)
  53. Johnson & Johnson: Revenue Share, By Region, 2024 (%)
  54. Regeneron Pharmaceuticals.: Net Sales, 2024-2035 ($ Billion)
  55. Regeneron Pharmaceuticals.: Revenue Share, By Segment, 2024 (%)
  56. Regeneron Pharmaceuticals.: Revenue Share, By Region, 2024 (%)
  57. GSK plc: Net Sales, 2024-2035 ($ Billion)
  58. GSK plc: Revenue Share, By Segment, 2024 (%)
  59. GSK plc: Revenue Share, By Region, 2024 (%)
  60. Others: Net Sales, 2024-2035 ($ Billion)
  61. Others: Revenue Share, By Segment, 2024 (%)
  62. Others: Revenue Share, By Region, 2024 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2024
Tables & Figures:110
Pages:229
Countries covered:17
Companies covered::13
Forecast CAGR:7.2%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies